Chlormethenmadinone acetate

Last updated
Chlormethenmadinone acetate
Chlormethenmadinone acetate.svg
Clinical data
Trade names Biogest, Sterolibrin, Antigest B, Agelin
Other namesSCH-12600; 6-Chloromethylene­dehydroacetoxy­progesterone; 17α-Acetoxy-6-chloro-16-methylene-6-dehydroprogesterone; 16-Methylene­chlormadinone acetate; 17α-Acetoxy-6-chloro-16-methylenepregna-4,6-diene-3,20-dione
Drug class Progestogen; Progestin; Progestogen ester
Identifiers
  • [(8R,9S,10R,13S,14S,17R)-17-Acetyl-6-chloro-10,13-dimethyl-16-methylidene-3-oxo-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl] acetate
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C24H29ClO4
Molar mass 416.94 g·mol−1
3D model (JSmol)
  • CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C
  • InChI=1S/C24H29ClO4/c1-13-10-19-17-12-21(25)20-11-16(28)6-8-22(20,4)18(17)7-9-23(19,5)24(13,14(2)26)29-15(3)27/h11-12,17-19H,1,6-10H2,2-5H3/t17-,18+,19+,22-,23+,24+/m1/s1
  • Key:MDTBKPVVPCIBIT-USYNNDFZSA-N

Chlormethenmadinone acetate (CMMA), also known as chlorsuperlutin, is a progestin medication which was developed in Czechoslovakia in the 1960s. [1] It has been used in combination with mestranol in birth control pills under the brand names Biogest, Sterolibrin, and Antigest B, [2] [3] and in veterinary medicine under the brand name Agelin. [4] Analogues of CMMA include bromethenmadinone acetate (bromsuperlutin), which was assessed but was never marketed, [3] [5] and melengestrol acetate (methylsuperlutin), which is used in veterinary medicine. [6]

See also

References

  1. ↑ Sterba R (1968). "New biological application of contraceptive steroids". Endocrinologia Experimentalis. 2 (2): 101–110. Archived from the original on 16 September 2018.
  2. ↑ Melich H (July 1972). "[Biogest]". Casopis Lekaru Ceskych (in Czech). 111 (30): 694–695. PMID   5079918. Archived from the original on 2018-09-16. Retrieved 2018-09-16.
  3. 1 2 Stĕrba R (March 1970). "[Towards a more physiological hormonal contraception]". Zentralblatt für Gynäkologie (in German). 92 (10): 303–312. PMID   4096927. Archived from the original on 2018-09-16. Retrieved 2018-09-16.
  4. ↑ Bekeová E, Krajnicáková M, Hendrichovský V, Maracek I (November 1995). "[Thyroid and ovarian hormones in ewes treated with gestagens and PMSG in the spring season]". Veterinární Medicína (in Slovak). 40 (11): 345–352. PMID   8659087. Archived from the original on 2018-09-16. Retrieved 2018-09-16.
  5. ↑ Štěrba, R. (1971). "On the Way to a More Physiological Hormonal Contraception". Current Problems in Fertility. pp. 154–158. doi:10.1007/978-1-4615-8651-7_28. ISBN   978-1-4615-8653-1. Archived from the original on 2018-09-16. Retrieved 2018-09-16.
  6. ↑ von Kunz W (8 March 2013). "Über neue Arzneimittel". In Denkewalter RG, Tishler M, Ehrhart G, Biel JH, Lum BK, Büchi J, Winter CA, Münzel K, Kunz W, Ariëns EJ, Labhardt F (eds.). Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques. Birkhäuser. pp. 407–. ISBN   978-3-0348-7059-7.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.